Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

U.S. Court of Appeals Weighs in on Hemp-derived Delta-8 THC Classification

By Jessica Gayle Tierney, Eric N. Heyer, Michelle Li, Joe Smith & Anna Stressenger on May 25, 2022
Email this postTweet this postLike this postShare this post on LinkedIn

Key Notes:

  • The Ninth Circuit found that delta-8 THC products are federally legal under the plain meaning of the definition of “hemp” set by the 2018 Farm Bill, making it the first circuit to find such products lawful.
  • The Ninth Circuit affirmed a preliminary injunction in favor of the trademark holder on a delta-8 THC product, finding that because the products were federally legal, they constituted “lawful use” in commerce for trademark purposes.
  • Relying on the plain language of the statute, the Ninth Circuit rejected arguments that delta-8 THC was synthetic and illegal under DEA’s interpretation, or that substances legalized under the 2018 Farm Bill had to be for industrial use and not human consumption.

The U.S. Court of Appeals for the Ninth Circuit has weighed in on the legal gray area that hemp-derived delta-8 THC has inhabited since the 2018 Agriculture Improvement Act (“2018 Farm Bill”) legalized hemp nationwide. The court’s conclusion is likely to inspire cautious optimism across the hemp and hemp-products industry, and contrasts with the increasing number of states that are prohibiting or regulating delta-8 THC products at the state level.

On May 19, 2022, a three-judge panel upheld a preliminary injunction issued by the United States District Court for the Central District of California against Boyd Street Distro, LLC, which stands accused of infringing AK Futures’ trademark on “Cake”-branded delta-8 THC vapor products. On appeal, Boyd Street Distro, LLC argued that AK Futures did not have a protectable trademark for its “Cake” products because delta-8 THC is illegal under federal law.

Affirming the grant of the preliminary injunction, the Ninth Circuit held that the delta-8 THC in AK Futures’ vapor products “fit comfortably within the statutory definition of ‘hemp.’” The Ninth Circuit reasoned that the plain meaning of the 2018 Farm Bill’s definition of “hemp” only required that there be less than 0.3% delta-9 THC, and that this “seemingly extends to downstream products and substances, so long as their delta-9 THC concentration does not exceed the statutory threshold” and are a derivative or extract of hemp. Because AK Futures attested that its products were hemp-derived and contained less than 0.3% delta-9 THC, the Ninth Circuit found that they were lawful and that the preliminary injunction was merited. The court noted that its decision was “necessarily tentative given the nature of preliminary relief.” In other words, “it is entirely possible that AK Futures may ultimately fail to show that its products stay within the acceptable delta-9 THC limitations,” but for now AK Futures’ declaration was sufficient to obtain an injunction.

In reaching this conclusion, the Ninth Circuit notably rejected two common arguments, raised by Boyd, against hemp-derived delta-8 THC’s legal status. The first argument was that according to the DEA, delta-8 remains a schedule I substance because its method of manufacture is “synthetically-derived.” The court explained that while the Farm Bill’s definition of hemp is broad, it is “unambiguous and precludes a distinction based on manufacturing method.” In other words, any contrary agency language is overridden by clear statutory text. The court noted that a recent DEA letter clarified that “synthetic” delta-8 THC is produced “from non-cannabis materials,” indicating that the court and the DEA agree that “the source of the product—not the method of manufacture—is the dispositive factor for ascertaining whether a product is synthetic.” Put simply, regardless of its method of manufacture, if delta-8 THC is derived from the Cannabis sativa L. plant, it is not synthetic.

The court also rejected Boyd’s argument that the substances legalized by the Farm Bill must be for an industrial purpose rather than for human consumption. In response, the court simply refused to recognize a distinction that Congress did not write into the Farm Bill. The court explained that “[r]egardless of the wisdom of legalizing delta-8 THC products, [it would] not substitute its own policy judgment for that of Congress. If Boyd Street is correct, and Congress inadvertently created a loophole legalizing vaping products containing delta-8 THC, then it is for Congress to fix its mistake.”

While this case offers an encouraging glimpse into a potentially brighter future for hemp-derived delta-8 THC products, it is important to note that this is just one Circuit’s interpretation. Other courts may disagree, and individual states may still prohibit the sale or possession of delta-8 THC products, and other hemp-derived products, within their borders. Therefore, unless Congress says differently, businesses selling hemp-derived delta-8 THC products should continue to abide by individual state rules. Thompson Hine LLP is available to assist vapor businesses with their compliance needs.

Photo of Jessica Gayle Tierney Jessica Gayle Tierney
Read more about Jessica Gayle TierneyEmail
Photo of Eric N. Heyer Eric N. Heyer

Eric is a partner in the firm’s Business Litigation practice group and leads the firm’s extensive and multi-disciplinary E-Cigarette and Vaping Industry practice. Eric started with Thompson Hine as a summer associate and has spent all but two years of his career at…

Eric is a partner in the firm’s Business Litigation practice group and leads the firm’s extensive and multi-disciplinary E-Cigarette and Vaping Industry practice. Eric started with Thompson Hine as a summer associate and has spent all but two years of his career at the firm.

Read more about Eric N. HeyerEmail
Show more Show less
Photo of Michelle Li Michelle Li

Michelle focuses her practice on assisting clients in a wide range of industries with trade remedy proceedings. Her experience includes representing clients before the U.S. Department of Commerce, U.S. International Trade Commission, U.S. Court of International Trade, and U.S. Court of Appeals for…

Michelle focuses her practice on assisting clients in a wide range of industries with trade remedy proceedings. Her experience includes representing clients before the U.S. Department of Commerce, U.S. International Trade Commission, U.S. Court of International Trade, and U.S. Court of Appeals for the Federal Circuit. She also advises on import entry clearance and other customs and importation issues involving food, drug, medical, and tobacco products regulated by the FDA and consumer products regulated by the U.S. Consumer Product Safety Commission.

Read more about Michelle LiEmail
Show more Show less
Photo of Joe Smith Joe Smith
Read more about Joe SmithEmail
Photo of Anna Stressenger Anna Stressenger
Read more about Anna StressengerEmail
  • Posted in:
    Business and Commercial, Intellectual Property
  • Blog:
    The Way on FDA
  • Organization:
    Thompson Hine LLP

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo